Dolors Capellà

2.4k total citations
51 papers, 1.6k citations indexed

About

Dolors Capellà is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dolors Capellà has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 13 papers in Pharmacology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dolors Capellà's work include Attention Deficit Hyperactivity Disorder (8 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Dolors Capellà is often cited by papers focused on Attention Deficit Hyperactivity Disorder (8 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Dolors Capellà collaborates with scholars based in Spain, United States and Colombia. Dolors Capellà's co-authors include Xavier Castells, Ruth Cunill, Xavier Vidal, Xavier Castells, Joan‐Ramon Laporte, Clara Pérez‐Mañá, Aurelio Tobı́as, Magı́ Farré, Miguel Casas and Josep Garre‐Olmo and has published in prestigious journals such as The Lancet, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Dolors Capellà

50 papers receiving 1.5k citations

Peers

Dolors Capellà
Patricia D. Kroboth United States
El‐Wui Loh Taiwan
Roy R. Reeves United States
Lars Tanum Norway
Michael Shannon United States
Bridin Murnion Australia
Emily A. Karanges Australia
L. Susan Wieland United States
Mehrul Hasnain United States
Sohan Deshpande United Kingdom
Patricia D. Kroboth United States
Dolors Capellà
Citations per year, relative to Dolors Capellà Dolors Capellà (= 1×) peers Patricia D. Kroboth

Countries citing papers authored by Dolors Capellà

Since Specialization
Citations

This map shows the geographic impact of Dolors Capellà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolors Capellà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolors Capellà more than expected).

Fields of papers citing papers by Dolors Capellà

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolors Capellà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolors Capellà. The network helps show where Dolors Capellà may publish in the future.

Co-authorship network of co-authors of Dolors Capellà

This figure shows the co-authorship network connecting the top 25 collaborators of Dolors Capellà. A scholar is included among the top collaborators of Dolors Capellà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolors Capellà. Dolors Capellà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castells, Xavier, et al.. (2022). Drug-induced Sudden Death: A Scoping Review. Current Drug Safety. 18(3). 307–317. 3 indexed citations
2.
Castells, Xavier, Josep Garre‐Olmo, Joan Vilalta‐Franch, et al.. (2019). Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer’s disease: a cumulative meta-analysis and trial sequential analysis. European Journal of Clinical Pharmacology. 75(12). 1659–1667. 9 indexed citations
3.
Turró‐Garriga, Oriol, Laia Calvó‐Perxas, Joan Vilalta‐Franch, et al.. (2018). Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales. International Journal of Geriatric Psychiatry. 33(5). 710–717. 16 indexed citations
4.
Bosch‐Barrera, Joaquim, et al.. (2017). [Teaching Bioethics to Students of Medicine with Problem-Based Learning (PBL)].. PubMed. 26(87). 303–9. 8 indexed citations
5.
6.
7.
Bosch‐Barrera, Joaquim, et al.. (2015). ENSEÑAR BIOÉTICA A ESTUDIANTES DE MEDICINA MEDIANTE EL APRENDIZAJE BASADO EN PROBLEMAS (ABP). Cuadernos de bioética. 26(87). 303–309. 3 indexed citations
8.
Cunill, Ruth, Xavier Castells, Aurelio Tobı́as, & Dolors Capellà. (2015). Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients. Psychopharmacology. 233(2). 187–197. 59 indexed citations
9.
Salgueiro, Esther, Gloria Manso, Xavier Castells, et al.. (2012). Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008. Maturitas. 74(1). 74–78. 9 indexed citations
10.
Castells, Xavier, Ruth Cunill, & Dolors Capellà. (2012). Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials. European Journal of Clinical Pharmacology. 69(3). 347–356. 30 indexed citations
11.
Pérez‐Mañá, Clara, Xavier Castells, Xavier Vidal, Miguel Casas, & Dolors Capellà. (2010). Efficacy of indirect dopamine agonists for psychostimulant dependence: A systematic review and meta-analysis of randomized controlled trials. Journal of Substance Abuse Treatment. 40(2). 109–122. 25 indexed citations
12.
Pérez, E., Sergio Abanades, Xavier Vidal, et al.. (2010). Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting. British Journal of Clinical Pharmacology. 70(5). 656–663. 105 indexed citations
13.
Castells, Xavier, Miguel Casas, Clara Pérez‐Mañá, et al.. (2010). Efficacy of Psychostimulant Drugs for Cocaine Dependence. Cochrane Database of Systematic Reviews. CD007380–CD007380. 96 indexed citations
14.
Castells, Xavier, Miguel Casas, Xavier Vidal, et al.. (2007). Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta‐analysis of randomized controlled clinical trials. Addiction. 102(12). 1871–1887. 54 indexed citations
15.
Capellà, Dolors, et al.. (2005). Cannabis y cannabinoides en el tratamiento del dolor neuropático. 20(4). 213–216. 5 indexed citations
16.
Montané, Eva, et al.. (2005). Scientific drug information in newspapers: sensationalism and low quality. The example of therapeutic use of cannabinoids. European Journal of Clinical Pharmacology. 61(5-6). 475–477. 15 indexed citations
17.
Laporte, Joan‐Ramon, et al.. (2004). Novedades sobre las potencialidades terapéuticas del Cannabis y el sistema cannabinoide. Medicina Clínica. 122(10). 390–398. 12 indexed citations
18.
Ibáñez, Luisa, Elena Ballarín, E. Pérez, et al.. (2000). Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug. European Journal of Clinical Pharmacology. 55(10). 761–764. 15 indexed citations
19.
Capellà, Dolors, Miquel Bruguera, Albert Figueras, & J R Laporte. (1999). Fluoxetine-induced hepatitis: why is postmarketing surveillance needed?. European Journal of Clinical Pharmacology. 55(7). 545–546. 14 indexed citations
20.
Capellà, Dolors, et al.. (1988). Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.. BMJ. 297(6650). 722–723. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia D. Kroboth Breakdown of academic impact, for papers by El‐Wui Loh Breakdown of academic impact, for papers by Roy R. Reeves Breakdown of academic impact, for papers by Lars Tanum Breakdown of academic impact, for papers by Michael Shannon Breakdown of academic impact, for papers by Bridin Murnion Breakdown of academic impact, for papers by Emily A. Karanges Breakdown of academic impact, for papers by L. Susan Wieland Breakdown of academic impact, for papers by Mehrul Hasnain Breakdown of academic impact, for papers by Sohan Deshpande
Rankless by CCL
2026